Mortality reduction with β-blockers in ischemic cardiomyopathy patients undergoing coronary artery bypass grafting

Congestive Heart Failure

Volumn 16, Issue 4, 2010, Pages 170-174

  Lin, Terence ^a   Hasaniya, Nahidh W ^b   Krider, Susan ^b   Razzouk, Anees ^b   Wang, Nan ^b   Chiong, Jun R ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION; SURGICAL MORTALITY; SYSTOLE; SYSTOLIC DYSFUNCTION; SYSTOLIC HEART FAILURE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTIHYPERTENSIVE AGENTS; CARDIOMYOPATHIES; CORONARY ARTERY BYPASS; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK REDUCTION BEHAVIOR; SHOCK, CARDIOGENIC;

EID: 77955161501     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2010.00146.x     Document Type: Article

References (32)

1. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984, 311:1333-1339.
2. Varnauskas E. Twelve-year follow-up of survival in the Randomized European Coronary Surgery Study. N Engl J Med 1988, 319:332-337.
3. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation 1983, 68:939-950.
4. Yusuf S, Zucker D, Peduzzi P. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994, 344:563-570.
5. Eagle KA, Guyton RA, Davidoff R. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 2004, 44:e213-e310.
6. O'Connor CM, Velazquez EJ, Gardner LH. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol 2002, 90:101-107.
7. Topkara VK, Cheema FH, Kesavaramanujam S. Coronary artery bypass grafting in patients with low ejection fraction. Circulation 2005, 112:I344-I350.
8. Filsoufi F, Rahmanian PB, Castillo JG. Results and predictors of early and late outcome of coronary artery bypass grafting in patients with severely depressed left ventricular function. Ann Thorac Surg 2007, 84:808-816.
9. Haraphongse M, Na-Ayudhya RK, Teo KK. The changing clinical profile of coronary artery bypass graft patients, 1970-89. Can J Cardiol 1994, 10:71-76.
10. Rutherford JD, Pfeffer MA, Moyé LA. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. Circulation 1994, 90:1731-1738.
11. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991, 325:293-302.
12. Packer M, Fowler MB, Roecker EB. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002, 106:2194-2199.
13. Poole-Wilson PA, Swedberg K, Cleland JG. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003, 362:7-13.
14. Okrainec K, Platt R, Pilote L. Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials. J Am Coll Cardiol 2005, 45:177-184.
15. Filion KB, Pilote L, Rahme E. Perioperative use of cardiac medical therapy among patients undergoing coronary artery bypass graft surgery: a systematic review. Am Heart J 2007, 154:407-414.
16. Ferguson TB, Coombs LP, Peterson ED. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 2002, 287:2221-2227.
17. Jessup M, Brozena S. Heart failure. N Engl J Med 2003, 348:2007-2018.
18. Abbott JD, Ahmed HN, Vlachos HA. Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 2007, 100:190-195.
19. Mangano DT, Browner WS, Hollenberg M. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990, 323:1781-1788.
20. Mangano DT, Browner WS, Hollenberg M. Long-term cardiac prognosis following noncardiac surgery. JAMA 1992, 268:233-239.
21. Raby KE, Goldman L, Creager MA. Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med 1989, 321:1296-1300.
22. Gottlieb SO, Weisfeldt ML, Ouyang P. Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. J Am Coll Cardiol 1987, 10:756-760.
23. Mangano DT, Layug EL, Wallace A. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996, 335:1713-1720.
24. Lindenauer PK, Pekow P, Wang K. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005, 353:349-361.
25. Wallace A, Layug B, Tateo I. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998, 88:7-17.
26. Yeager RA, Moneta GL, Edwards JM. Reducing perioperative myocardial infarction following vascular surgery. The potential role of ß-blockade. Arch Surg 1995, 130:869-872.
27. Stone JG, Foëx P, Sear JW. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 1988, 68:495-500.
28. Comprehensive heart failure practice guideline. J Card Fail 2006, 12:e1-e2.
29. Phillips HR, O'Connor CM, Rogers J. Revascularization for heart failure. Am Heart J 2007, 153:65-73.
30. Goyal A, Alexander JH, Hafley GE. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. Ann Thorac Surg 2007, 83:993-1001.
31. Weightman WM, Gibbs NM, Sheminant MR. Drug therapy before coronary artery surgery: nitrates are independent predictors of mortality and beta-adrenergic blockers predict survival. Anesth Analg 1999, 88:286-291.
32. Ferguson TB, Peterson ED, Coombs LP. Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial. JAMA 2003, 290:49-56.